SEC Form 4 · accession 0001209191-16-098103
PharMerica CORP · PMC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory S Weishar
Officer — Chief Executive Officer · Director
Period of report
Feb 10, 2016
Accepted (ET)
Feb 12, 2016 · 4:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388195
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 par value | Feb 10, 2016 | M | 166,664 | $14.89 | A | 826,834 | D | |
| Common Stock, $0.01 par value | Feb 10, 2016 | F | 123,090 | $27.75 | D | 703,744 | D | |
| Common Stock, $0.01 par value | holding | — | — | — | 1,500 | I | By Son |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $14.89 | Feb 10, 2016 | M | 166,664 | D | — | Mar 3, 2016 | Common Stock, $.01 par value | 166,664 | 0 | D |
Explanation of responses
- F1The options vested in the following amounts on the following dates: 41,666 options on 03/03/2010, 41,666 options on 03/03/2011, 41,666 options on 03/03/2012, and 41,666 options on 03/03/2013.